Aminoacid. No CYP-interactions.

(To be edited, initial data ST OCT 04) Amino acid plasmin inhibitor administered as tablets or infusion in situations with fibrinolysis or risk for fibrinolytic bleeding. Metabolized by acetylation and deamination

Uneventful use reported in 4 patients with acute porphyria.